# Endothelin Antagonism in ANCA Vasculitis

> **NCT02062346** · NA · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 64 (actual)

## Conditions studied

- Vasculitis

## Interventions

- **DRUG:** BQ123
- **DRUG:** BQ123/788
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02062346
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2023-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062346, "Endothelin Antagonism in ANCA Vasculitis". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02062346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*